Biolase inc.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the ...BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2020, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in ...IRVINE, Calif., June 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately $6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to …

from BIOLASE, Inc. 3 years ago — via Parallel Uploader. Recommended; Description; Comments. Laser Bacterial Reduction (LBR). Real time 5 minutes! 00:25 ...

BIOLASE India Pvt. Ltd. Fun Republic Road, Off New Link Road Andheri (W), Mumbai — 400 053. Tel: +91 22 6195 3400

Apr 20, 2021 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public ...LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …The U.S. Food and Drug Administration (FDA) approved Waterlase for the treatment of hard tissue in October 1998, one month before Jeffrey W. Jones was appointed ...Validates BIOLASE REPAIR ® Perio Protocol is a Superior Alternative as it pertains to patient reported outcomes.. LAKE FOREST, Calif., Nov. 8, 2023 /PRNewswire/ -- BIOLASE, Inc.(NASDAQ: BIOL ...

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

150 Royall St. Suite V. Canton MA 02021. Under the rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each warrant issued in a private placement transaction that was consummated on June 10, 2020 (on an as-if-converted-to-common-stock basis) held on the Record Date (July 1, 2020).

Feb 27, 2023 · LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has ... BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.Apr 28, 2022 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ... Our Story. BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser …BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...At BIOLASE, John’s vision is to raise a generation of kids not afraid of going to the dentist. He brings over 40 years of substantial leadership and technical experience in finance …

BIOLASE Technology, Inc. (BIOLASE), a dental devices company, has promoted its chief financial officer (CFO) David M. Mulder to the company as new chief executive officer (CEO), effective March 5, 2009. Mulder succeeds Jake St. Philip, who has resigned his positions as CEO and director of the company to pursue other interests. …COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ...Nov 20, 2023 · BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year. LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J …BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...

Feb 10, 2021 · FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less underwriting discounts and commissions.

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, …Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. View Historical Data. …Диодный лазер. Один из новейших диодных лазеров - Epic 10, применяемых в клинике "Стоматология Лобачевых" разработан и производится в США компанией Biolase.…LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J …Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BIOLASE India Pvt. Ltd. Fun Republic Road, Off New Link Road Andheri (W), Mumbai — 400 053. Tel: +91 22 6195 3400BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

The industry leading webinar series adds new dates and content for multi-specialty support. LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the extension of its digital learning webinar series "Advancing Dentistry" for remote dental training and …

Tick-borne hemoparasitic (TBH) infections are a major problem affecting livestock industries worldwide, particularly in tropical and subtropical regions. This study …

Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.LAKE FOREST, Calif., May 4, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 …LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today …May 11, 2023 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live ... Prior to joining BIOLASE, Brown was a co-founder of Kreativ, Inc., an international advanced dental equipment company, from 1995 until it was acquired in 1999 by Welch-Allyn, Inc., at which time he served as Director of New Product Development and Board Director for Welch-Allyn Kreativ, Inc. until 2002. COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ...BIOLASE, Inc. 10 Jan, 2023, 08:00 ET. LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today ...Sep 18, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, …1997. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.

LAKE FOREST, Calif., March 6, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced plans to launch a second season of the popular podcast series ...Biolase India Private Limited is a Private incorporated on 25 May 2011. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. Its authorized …BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.Instagram:https://instagram. bed bath and beyond jake freemansun tickerishares 0 3 month treasury bond etfvmware stock prices BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental ... forex robotgbci IRVINE, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today its Waterlase Pediatric Dental Academy (WPDA), for Waterlase pediatric dentists. The WPDA will provide clinicians with an immersive training experience through peer-led learning, best practice sharing and on-going mentorship, to … quarter years worth money Dec 1, 2023 · Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental ... BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...